 They also may be useful in treatment of methicillin-resistant "Staphylococcus aureus" (MRSA).They are in pre-clinical development and has not yet started clinical trials.Myxopyronin was first isolated in 1983 from a soil bacterium by Werner Kohl and Herbert Irschik at the Helmholtz Centre for Infection Research (former GBF).